1. Home
  2. IPI vs ACIU Comparison

IPI vs ACIU Comparison

Compare IPI & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPI
  • ACIU
  • Stock Information
  • Founded
  • IPI 2000
  • ACIU 2003
  • Country
  • IPI United States
  • ACIU Switzerland
  • Employees
  • IPI N/A
  • ACIU N/A
  • Industry
  • IPI Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • ACIU Biotechnology: Pharmaceutical Preparations
  • Sector
  • IPI Industrials
  • ACIU Health Care
  • Exchange
  • IPI Nasdaq
  • ACIU Nasdaq
  • Market Cap
  • IPI 475.8M
  • ACIU 189.1M
  • IPO Year
  • IPI 2008
  • ACIU 2016
  • Fundamental
  • Price
  • IPI $34.84
  • ACIU $2.06
  • Analyst Decision
  • IPI Strong Sell
  • ACIU Strong Buy
  • Analyst Count
  • IPI 1
  • ACIU 1
  • Target Price
  • IPI $19.00
  • ACIU $12.00
  • AVG Volume (30 Days)
  • IPI 146.8K
  • ACIU 124.8K
  • Earning Date
  • IPI 08-04-2025
  • ACIU 08-05-2025
  • Dividend Yield
  • IPI N/A
  • ACIU N/A
  • EPS Growth
  • IPI N/A
  • ACIU N/A
  • EPS
  • IPI N/A
  • ACIU N/A
  • Revenue
  • IPI $217,865,000.00
  • ACIU $32,014,254.00
  • Revenue This Year
  • IPI $11.06
  • ACIU N/A
  • Revenue Next Year
  • IPI N/A
  • ACIU $533.21
  • P/E Ratio
  • IPI N/A
  • ACIU N/A
  • Revenue Growth
  • IPI N/A
  • ACIU 91.20
  • 52 Week Low
  • IPI $20.75
  • ACIU $1.43
  • 52 Week High
  • IPI $39.01
  • ACIU $4.26
  • Technical
  • Relative Strength Index (RSI)
  • IPI 41.73
  • ACIU 54.21
  • Support Level
  • IPI $34.36
  • ACIU $1.94
  • Resistance Level
  • IPI $37.84
  • ACIU $2.15
  • Average True Range (ATR)
  • IPI 1.09
  • ACIU 0.16
  • MACD
  • IPI -0.16
  • ACIU -0.00
  • Stochastic Oscillator
  • IPI 18.13
  • ACIU 72.22

About IPI Intrepid Potash Inc

Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, which is also the location of the firm's production facilities.

About ACIU AC Immune SA

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

Share on Social Networks: